Norman C. Simon
Partner
Herbert Smith Freehills Kramer LLP
Norman C. Simon is a seasoned trial lawyer with significant complex commercial litigation experience.
Recognized as one of the top advertising litigators in the US, Norm represents some of the world’s most iconic brands in false advertising disputes in courts across the country under the Lanham Act and in class action litigation brought pursuant to consumer fraud statutes, as well as in challenges before the National Advertising Division (NAD) and National Advertising Review Board (NARB).
Chambers USA — which rates the firm's Advertising Litigation practice as one of the nation’s best — has consistently recognized Norm as a leading practitioner, calling him a “highly skilled trial lawyer” and “one of the elite advertising attorneys in the country.” Clients have described Norm to Chambers as “at the top of his profession”; “confident and articulate in the courtroom”; “a sophisticated and passionate advocate”; “excellent in every respect; responsive, keenly intelligent, practical and strategic”; and “a skilled, thoughtful and pragmatic professional who is extraordinarily responsive, organized and prepared.” Legal 500 US has long included Norm in its Hall of Fame for advertising litigation. Norm also has been named a Litigation Star by Benchmark Litigation and by Lawdragon 500: Leading Litigators in America.
Norm’s complex commercial litigation experience is broad and includes contract, licensing, partnership and employment disputes, as well as regulatory and internal investigations. He has represented several leading law firms in disputes with their former partners and other firms. He represented one of the world’s leading biotechnology companies in a federal court action with a multinational pharmaceutical corporation over the parties’ collaboration agreement to commercialize a migraine drug. Norm also represented a large financial institution in a multiyear arbitration in which a three-member panel rejected a former employee’s claims for breach of contract and fraud. He represented that same client in a federal action brought by a former high-level employee alleging various breaches of contract; all claims were successfully dismissed on summary judgment. Norm successfully defended a biotechnology company in an arbitration commenced by a university claiming underpayment of royalties under a research and licensing agreement for contributions to the development of a bestselling anticoagulant antibody. He also represented a senior scientist of a Fortune 500 pharmaceutical company in government investigations and civil proceedings involving the development and marketing of a leading pain medication.
A member of the firm’s Pro Bono Committee, US, Norm has litigated a large number of pro bono cases, several of which have been high-profile and precedent-setting in the area of LGBTQ+ civil rights. He has been recognized for this work by being included on City & State New York’s Pride Power 100 list and being named a “Notable LGBTQ Leader and Executive” by Crain’s New York Business.
Recognized as one of the top advertising litigators in the US, Norm represents some of the world’s most iconic brands in false advertising disputes in courts across the country under the Lanham Act and in class action litigation brought pursuant to consumer fraud statutes, as well as in challenges before the National Advertising Division (NAD) and National Advertising Review Board (NARB).
Chambers USA — which rates the firm's Advertising Litigation practice as one of the nation’s best — has consistently recognized Norm as a leading practitioner, calling him a “highly skilled trial lawyer” and “one of the elite advertising attorneys in the country.” Clients have described Norm to Chambers as “at the top of his profession”; “confident and articulate in the courtroom”; “a sophisticated and passionate advocate”; “excellent in every respect; responsive, keenly intelligent, practical and strategic”; and “a skilled, thoughtful and pragmatic professional who is extraordinarily responsive, organized and prepared.” Legal 500 US has long included Norm in its Hall of Fame for advertising litigation. Norm also has been named a Litigation Star by Benchmark Litigation and by Lawdragon 500: Leading Litigators in America.
Norm’s complex commercial litigation experience is broad and includes contract, licensing, partnership and employment disputes, as well as regulatory and internal investigations. He has represented several leading law firms in disputes with their former partners and other firms. He represented one of the world’s leading biotechnology companies in a federal court action with a multinational pharmaceutical corporation over the parties’ collaboration agreement to commercialize a migraine drug. Norm also represented a large financial institution in a multiyear arbitration in which a three-member panel rejected a former employee’s claims for breach of contract and fraud. He represented that same client in a federal action brought by a former high-level employee alleging various breaches of contract; all claims were successfully dismissed on summary judgment. Norm successfully defended a biotechnology company in an arbitration commenced by a university claiming underpayment of royalties under a research and licensing agreement for contributions to the development of a bestselling anticoagulant antibody. He also represented a senior scientist of a Fortune 500 pharmaceutical company in government investigations and civil proceedings involving the development and marketing of a leading pain medication.
A member of the firm’s Pro Bono Committee, US, Norm has litigated a large number of pro bono cases, several of which have been high-profile and precedent-setting in the area of LGBTQ+ civil rights. He has been recognized for this work by being included on City & State New York’s Pride Power 100 list and being named a “Notable LGBTQ Leader and Executive” by Crain’s New York Business.